Status:

TERMINATED

Search to Advance Limited Use of Opioids Pilot: Optimization of Non-Opioid Therapy With a Steroid

Lead Sponsor:

Rutgers, The State University of New Jersey

Conditions:

Pain Management

Eligibility:

All Genders

18-99 years

Phase:

PHASE4

Brief Summary

To provide health care professionals, including dentists, with the best possible evidence for clinical decision making when deciding upon analgesics and use of corticosteroid for acute post-surgical p...

Detailed Description

The primary objective of this pilot study is to determine whether a STEROID (1 dose of 8 mg dexamethasone) is superior to CONTROL in pain management and patient satisfaction observed for seven days fo...

Eligibility Criteria

Inclusion

  • Be able to understand the informed consent.
  • Provide signed and dated informed consent form
  • Be able to understand all directions for data gathering instruments in English
  • Be willing and able to comply with all study procedures, including having a smart phone, and be available for the duration of the study
  • Planning to undergo extraction of one or more partial or fully impacted mandibular 3rd molars
  • Be 18 years or older
  • Be in good general health as evidenced by medical history
  • Women must agree to use one of the following methods of contraception while participating in this study:
  • contraceptive pill
  • intra-uterine device
  • condoms
  • abstinence

Exclusion

  • • History of gastrointestinal bleeding, diverticulitis and/or ulcerative disease
  • History of renal disease (excluding kidney stones)
  • History of hepatic disease
  • History of cardiovascular disease (MI or stroke with the past 6 months)
  • History of bleeding disorder
  • History of Sickle Cell disease
  • Active or untreated asthma
  • History of known allergic reaction to ibuprofen, acetaminophen, or dexamethasone
  • History of myasthenia gravis
  • Currently immunocompromised
  • Currently have a fungal infection
  • Currently taking steroids
  • Currently pregnant or lactating
  • Currently taking CYP3A4 inhibitors

Key Trial Info

Start Date :

November 27 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 31 2024

Estimated Enrollment :

8 Patients enrolled

Trial Details

Trial ID

NCT06074263

Start Date

November 27 2023

End Date

December 31 2024

Last Update

June 4 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Rutgers School of Dental Medicine

Newark, New Jersey, United States, 07103